Caregen Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
May 04, 2023 at 04:54 am EDT
Share
Caregen Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 24,670.95 million compared to KRW 15,292.91 million a year ago. Net income was KRW 14,146.95 million compared to KRW 7,528.4 million a year ago.
Basic earnings per share from continuing operations was KRW 1,440 compared to KRW 768 a year ago. Diluted earnings per share from continuing operations was KRW 1,440 compared to KRW 768 a year ago. Basic earnings per share was KRW 1,440 compared to KRW 768 a year ago.
Caregen Co., LTD is a Korea-based company mainly engaged in the manufacture of cosmeceuticals and dermal fillers. The Company manufactures HSR CEs which used for improving facial wrinkles and strengthening protect wet under the brand name of Dermaheal, aquashines which used for keeping the shin whitening and promoting skin cells activation under the brand name of REVOFIL, HL CEs which used for treating hair loss, hair filler excell C'rums which used for promoting hair growth and preventing hair lose, LL CEs which used for promoting fat decomposition and prevent fat accumulation, hydra B5 Gels, ultra AW500s, eye filler masks, efficacy raw materials including growth facors and biomimetic peptides, and others. The Company distributes its products within domestic market and to overseas markets.
CAREGEN CO., LTD. 
